Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Principal Investigator: Thompson, J
An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
Principal Investigator: George, Saby
Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation
Principal Investigator: Huizinga, Heather E
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Principal Investigator: Fountzilas, Christos
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Principal Investigator: Ivanick, Nathaniel M
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
Principal Investigator: Levine, Ellis G
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Principal Investigator: Hassan, Hamza
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
Principal Investigator: Dy, Grace K
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Principal Investigator: Dakwar, Anthony
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
Principal Investigator: Devonish, Julia A
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Principal Investigator: Holtan, Shernan G
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Principal Investigator: O'Connor, Richard J
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Principal Investigator: Hillengass, Jens
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Principal Investigator: Levine, Ellis G
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Principal Investigator: Singh, Anurag K
Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
Principal Investigator: Ray, Andrew D
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
Principal Investigator: Zsiros, Emese
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
Principal Investigator: Storer, Andrew C
A Study of AMG 193 in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
Principal Investigator: Dy, Grace K
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
Principal Investigator: Green, Steven D
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
Principal Investigator: Malek, Ehsan
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Principal Investigator: Aly, Ahmed A
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
Principal Investigator: Zsiros, Emese
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Principal Investigator: Gupta, Ajay
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Principal Investigator: Wang, Eunice S